Literature DB >> 24176566

Surgery versus SABR for NSCLC.

Drew Moghanaki1, Tomer Karas.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24176566     DOI： 10.1016/S1470-2045(13)70445-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.

Authors:  Alexander V Louie; George B Rodrigues; David A Palma; Suresh Senan
Journal:  Oncologist       Date:  2014-06-20

Review 2.  Is surgery still the optimal treatment for stage I non-small cell lung cancer?

Authors:  Drew Moghanaki; Joe Y Chang
Journal:  Transl Lung Cancer Res       Date:  2016-04

3.  A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.

Authors:  Christopher Cao; Daniel Wang; Caroline Chung; David Tian; Andreas Rimner; James Huang; David R Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2018-09-15       Impact factor: 5.209
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.